NCT06566833

Brief Summary

the primary aim of the study is remineralization of early carious lesions in primary teeth using different remineralizing agents of different remineralizing strategies when applied in an intensive mode. The secondary aim of the study is to compare their antibacterial effect against streptococcus mutans and their effect on reducing the size of the lesions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 22, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2024

Completed
Last Updated

January 29, 2025

Status Verified

January 1, 2025

Enrollment Period

1.2 years

First QC Date

August 9, 2024

Last Update Submit

January 27, 2025

Conditions

Keywords

curodont repair fluoride plusCPP-ACPFsodium fluoride varnishguided enamel regeneration

Outcome Measures

Primary Outcomes (1)

  • Assessing the remineralization of early carious lesions in primary teeth

    comparing the remineralization effect of different remineralizing agents both qualitatively by comparing the change in ICDAS -11 criteria and quantitatively by using laser fluorescence scores using kavo DIAGNOdent classic after intensive mode of application of the different remineralizing agents

    3,6,9 and12 months

Secondary Outcomes (2)

  • comparing the change in esthetic appearance of early carious lesion before and after treatment

    12 months

  • comparing the antibacterial effect of different remineralizing agents against streptococcus mutans

    3 months

Study Arms (3)

curodont repair fluoride plus

EXPERIMENTAL

self-assembling peptide (p11-4) with 0.05% sodium fluoride

Drug: self assmbling peptide p11-4 combined with 0.05% fluoride

CPP-ACPF varnish

EXPERIMENTAL

casein phoshphopeptide amorphous calcium phosphate fluoride (CPP-ACPF )

Drug: Casein phosphopeptide amorphous calcium phosphate

5 % sodium fluoride varnish

ACTIVE COMPARATOR

5% sodium fluoride varnish

Drug: 5% sodium fluoride varnish

Interventions

biomimetic remineralizing agent

Also known as: SAP P11-4
curodont repair fluoride plus

remineralizing agents that acts as a fluoride booster

Also known as: CPP-ACPF
CPP-ACPF varnish

remineralizing agent that is used as a gold standard for remineralization

Also known as: 5% NaF
5 % sodium fluoride varnish

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • healthy children
  • age range 3-6
  • at least 2 early carious lesions

You may not qualify if:

  • Children presenting with special health care needs or undergoing medical treatment for chronic or acute diseases.
  • Application of fluoride varnish less than 3 months prior to study treatment.
  • Any metabolic disorders affecting bone turnover.
  • Concurrent participation in another clinical trial.
  • Patients receiving any antibiotic within 1 month prior to plaque sample collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karin Dowidar

Alexandria, Professor, Egypt

Location

Related Publications (1)

  • Mekky AI, Dowidar KML, Talaat DM. Casein Phosphopeptide Amorphous Calcium Phosphate Fluoride Varnish in Remineralization of Early Carious Lesions in Primary Dentition: Randomized Clinical Trial. Pediatr Dent. 2021 Jan 15;43(1):17-23.

    PMID: 33662244BACKGROUND

MeSH Terms

Interventions

Fluoridescasein phosphopeptide-amorphous calcium phosphate nanocomplex

Intervention Hierarchy (Ancestors)

AnionsIonsElectrolytesInorganic ChemicalsHydrofluoric AcidFluorine Compounds

Study Officials

  • karin dowidar, professor

    faculty of Dentistry, Alexandria university, Egypt

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

August 9, 2024

First Posted

August 22, 2024

Study Start

August 15, 2023

Primary Completion

October 15, 2024

Study Completion

October 15, 2024

Last Updated

January 29, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

only the results of the primary and secondary outcomes of the study will be published after study completion

Locations